Become a partner

PARTNER WITH MBA PHARMA INNOVATION

Advanced Wound Care. Shared Vision. Sustainable Growth.

MBA PHARMA INNOVATION  is expanding its international partner network to make advanced wound-care solutions accessible in more markets. We work with distributors and private-label partners that share our commitment to science, quality and patient-focused care.

BUILDING THE FUTURE OF WOUND CARE TOGETHER

A differentiated technology platform, complementary formulations and flexible partnership models designed for long-term value.

Why Partner with MBA PHARMA INNOVATION?

KAdermin combines scientific differentiation with practical wound-care solutions developed for real clinical needs. Our partnership approach is collaborative and adaptable, supporting each market from initial evaluation through launch and sustainable development.

  • Differentiated SCX Technology platform for advanced antimicrobial protection
  • Complementary wound-care formulations for acute and chronic wounds, adapted to both exudative and non-exudative wound conditions
  • A growing portfolio across wound care and targeted local-care applications
  • Medical, scientific and product-training support for healthcare professionals
  • Commercial and marketing materials adapted to local market requirements
  • A collaborative, long-term approach focused on responsible market development

Partnership Opportunities

DISTRIBUTION

Introduce KAdermin in your market with product education and launch support.

PRIVATE LABEL

Develop differentiated wound-care products under your own brand.

From Science to Commercial Success

Successful partnerships are built on more than product availability. MBA PHARMA INNOVATION connects scientific differentiation, healthcare-professional confidence and disciplined commercial development to support sustainable growth.

Scientific Differentiation

A technology platform designed to address complementary needs in wound management.
  • Patented SCX Technology combining functionalised silicon dioxide, silver ions and chlorhexidine
  • Hyaluronic acid in both principal wound-care formulations
  • Kaolin in the spray and dimethicone in the cream for formulation-specific support

Healthcare-Professional Engagement

Resources that help partners communicate the product rationale clearly and responsibly.
  • Medical and scientific product information
  • Educational materials and product training
  • Support for healthcare-professional engagement and responsible product communication

Commercial Development

A structured route from market assessment to launch and growth.
  • Portfolio and opportunity evaluation
  • Regulatory and artwork coordination
  • Launch planning, marketing support and market expansion

A Clear Path from Opportunity to Growth

DISCOVER

We understand your market, capabilities and objectives.

ALIGN

Together, we select the products, territory and cooperation model.

PREPARE

We coordinate product, regulatory, training and launch materials.

LAUNCH

We support market introduction and professional communication.

GROW

We review performance and develop new opportunities together.

Who We Work With

We welcome conversations with organisations seeking scientifically differentiated and commercially relevant wound-care opportunities, including:
  • Pharmaceutical distributors
  • Medical-device and wound-care specialists
  • Pharmacy and healthcare groups
  • Strategic commercial  and private-label partners

What We Look for in a Partner

  • Strong knowledge of the local healthcare market
  • A responsible approach to compliance and product communication
  • Established relationships with relevant healthcare channels
  • A long-term vision for brand and market development


Let’s Build the Next Growth Chapter Together

If you are interested in distributing KAdermin or developing a private-label collaboration, we would be pleased to discuss the potential fit for your market and organisation.

BECOME A MBA PHARMA PARTNER
Complete the partnership enquiry form below and our business-development team will contact you to discuss the opportunity.







     

    PRODUCTS OF INTEREST

     

    BUSINESS INTEREST

     

    NOTES / FOLLOW-UP